Insights: Publications Will There Be a Legislative Push to Reform Patent Eligibility Requirements During the Biden Administration?

Kilpatrick Townsend MEMO|Biopharma Industry Blog

On March 5, 2021, bipartisan members of the Senate Committee on the Judiciary Subcommittee on Intellectual Property, Senators Tillis (R-NC), Hirono (D-HI), Cotton (R-AR) and Coons (D-DE), sent a letter to the USPTO’s Commissioner for Patents regarding the state of patent eligibility jurisprudence in the United States,” writing that “since the Supreme Court’s landmark decisions in Alice Corp. v. CLS Bank International and Mayo Collaborative Services v. Prometheus Laboratories, Inc., there has been a lack of consistency and clarity in our nation’s patent eligibility laws.”

Related People

Latest Thinking

View more Insights
Insights Center
If you would like to receive related insights and information from Kilpatrick Townsend, please provide your contact details by filling out the form and clicking “Agree.” If you would like to access the PDF only, please click “Download Only.”